| Ytd | 59.43% | |
| 1y | 46.67% |
| Open | 107.09 | Prev Close | 107.95 | Low | 105.49 | High | 107.18 | Mkt Cap | 7.03B |
| Vol | 100.75K | Avg Vol | 994.21K | EPS | 5.97 | P/E | 18.08 | Forward P/E | 18.42 |
| Beta | -0.06 | Short Ratio | 6.33 | Inst. Own | 116.38% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 102.17 | 200-d Avg | 76.55 | 1yr Est | 112.00 |
Truist Securities analyst Richard Newitter maintains Lantheus Holdings (NASDAQ:LNTH) with a Buy a
Mizuho analyst Anthony Petrone maintains Lantheus Holdings (NASDAQ:LNTH) with a Market Outperform
Leading pharmaceutical executive brings over 4 decades of commercial, M&A, and governance leadership
B. Riley Securities analyst Justin Walsh maintains Lantheus Holdings (NASDAQ:LNTH) with a Buy and
On Friday, the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter to Lantheus
Lantheus receives FDA Complete Response Letter for LNTH-2501. William Blair pushes Octevy sales outl
Citizens analyst David Turkaly reiterates Lantheus Holdings (NASDAQ:LNTH) with a Market Outperfor
U.S. stock futures up, watch Concentrix Corp, Lantheus Holdings, AeroVironment, Viridian Therapeutic
The U.S. Food and Drug Administration declined to approve Lantheus Holdings' diagnostic imaging
Lantheus Holdings, Inc. ("Lantheus" or "Company") (NASDAQ:LNTH), the leading radioph
BEDFORD, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or “Company”)
Lantheus Holdings, Inc. (LNTH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 20
BEDFORD, Mass., June 03, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Compan
BEDFORD, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus") (NASDAQ: LNTH
Mizuho analyst Anthony Petrone maintains Lantheus Holdings (NASDAQ:LNTH) with a Outperform and ra
BEDFORD, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company
Lantheus Holdings is weighing a potential sale after getting a takeover offer from private-equ
https://www.bloomberg.com/news/articles/2026-05-22/lantheus-is-said-to-weigh-sale-following-offer-fr
BEDFORD, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH
BEDFORD, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH
Biotech dealmaking accelerated heading into the JPM 2026 Healthcare Conference as large drugmakers f
Truist Securities analyst Richard Newitter reiterates Lantheus Holdings (NASDAQ:LNTH) with a Buy
Lantheus NASDAQ: LNTH reported what management described as a strong start to 2026, citing solid per
Lantheus Holdings Inc (NASDAQ:LNTH) reported upbeat earnings for the first quarter on Thursday.
Lantheus Holdings Inc (NASDAQ:LNTH) reported upbeat Q1 earnings, reaffirmed guidance, and received p
Citizens analyst David Turkaly maintains Lantheus Holdings (NASDAQ:LNTH) with a Market Outperform
Wall Street analysts changed outlook on top names. Includes upgrades/downgrades. Check analyst rati
Mizuho analyst Anthony Petrone maintains Lantheus Holdings (NASDAQ:LNTH) with a Outperform and ra
Lantheus Holdings, Inc. (LNTH) Q1 2026 Earnings Call Transcript
Lantheus Holdings (NASDAQ:LNTH) affirms FY2026 Adj EPS guidance from $5.00-$5.25 to $5.00-$5.25 vs $
Lantheus Holdings (NASDAQ:LNTH) reported quarterly earnings of $1.46 per share which beat the analys
BEDFORD, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (
Shares of Lantheus Holdings were added after the company received FDA approval of its key product Tr
Mizuho analyst Anthony Petrone maintains Lantheus Holdings (NASDAQ:LNTH) with a Outperform and ra
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH - Get Free Report) have received an average rating o
Lantheus Holdings faces a three-month FDA PDUFA extension for OCTEVY, delaying potential approval an
Lantheus (NASDAQ: LNTH - Get Free Report) and High Tide (NASDAQ: HITI - Get Free Report) are both me
U.S. stock futures up, Korn Ferry, ZIM, Lantheus, HPE, and Caseys General Stores in focus for earnin
On Oct. 29, Citigroup analyst Jon Tower maintained Cava Group with a Neutral and raised the price ta
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings
Gainers Vericity, Inc. (NASDAQ: VERY) shares climbed 87.4% to $11.12 after iA Financial Group an
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
Gainers
U.S. stocks traded slightly lower, with the Dow Jones dropping around 30 points on Thursday. Here ar
Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly e